Učitavanje...
Uncommon response of cisplatin and etoposide for treatment of advanced medullary thyroid carcinoma
Systemic treatment of Medullary thyroid carcinoma (MTC) is currently limited to the use of a tyrosine kinase inhibitor. Cytotoxic chemotherapy is not routinely recommended in the earlier lines of treatment due to the lack of efficacy. We describe a patient with locally advanced MTC who had an uncomm...
Spremljeno u:
| Izdano u: | Clin Case Rep |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5628208/ https://ncbi.nlm.nih.gov/pubmed/29026560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1123 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|